Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000062391-95-000013
Filing Date
1995-07-10
Accepted
1995-07-10 00:00:00
Documents
3
Group Members
H PHARMA ACQUISITION CORP.HOECHST CORPHOECHST CORPORATIONMARION MERRELL DOW INC.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMEND.3 AND INITIAL 13D FILING OF NAMED PARTIES SC 13D 20081
2 99.C AGMT TO FILE JOINTLY EX-99 1237
3 99.E DIRECTORS AND OFFICERS EX-99 9513
  Complete submission text file 0000062391-95-000013.txt   33202
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-37954 | Film No.: 95552747
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address ROUTE 202-206 PO BOX 2500 SOMERVILLE NJ 08876-1258
Business Address ROUTE 202-206 PO BOX 2500 SOMERVILLE NJ 08876-1258 9082312000
HOECHST CORP (Filed by) CIK: 0000745637 (see all company filings)

EIN.: 221862783 | State of Incorp.: DE | Fiscal Year End: 1231